ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)

KOSDAQ:034940 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,119	2,097	2,047	4,526	5,749	4,164
Short-Term Investments	195.64	2,549	1,538	1,537	1,587	1,706
Trading Asset Securities	-	800.73	775.02	2,386	2,849	3,176
Cash & Short-Term Investments	1,315	5,447	4,361	8,449	10,184	9,046
Cash Growth	-78.70%	24.93%	-48.39%	-17.04%	12.59%	-37.57%
Accounts Receivable	17,983	18,250	20,230	22,727	20,884	21,546
Other Receivables	2,290	1,818	2,593	2,731	2,359	2,024
Receivables	20,732	20,948	23,900	27,603	24,867	25,039
Inventory	12,923	12,446	13,012	10,869	10,286	12,581
Prepaid Expenses	-	204.88	87.45	94.42	118.8	86.24
Other Current Assets	655	693.01	796.44	1,183	1,048	597.9
Total Current Assets	35,625	39,740	42,157	48,200	46,504	47,350
Property, Plant & Equipment	20,029	19,712	20,370	24,999	24,074	22,190
Long-Term Investments	3,069	3,068	2,792	2,935	3,678	3,163
Goodwill	-	-	-	-	46.78	46.78
Other Intangible Assets	715.18	769	803.4	806.87	795.5	583.5
Long-Term Accounts Receivable	-	0	1,054	1,054	-	-
Long-Term Deferred Tax Assets	1,303	1,370	1,499	1,401	945.32	1,671
Other Long-Term Assets	6,205	6,662	5,544	6,028	4,049	6,377
Total Assets	69,446	71,320	74,221	85,639	80,512	82,377
Accounts Payable	4,310	4,865	5,501	4,994	3,685	3,599
Accrued Expenses	-	3,516	3,494	2,765	2,775	2,664
Short-Term Debt	22,150	20,750	14,550	14,554	12,794	4,450
Current Portion of Long-Term Debt	902.39	448.61	-	-	-	3,700
Current Portion of Leases	661.41	629.07	633.15	637.5	684.07	745.25
Current Unearned Revenue	-	140.5	153.42	122.27	88.1	125.71
Other Current Liabilities	9,050	6,306	4,847	4,255	4,236	3,894
Total Current Liabilities	37,073	36,656	29,178	27,328	24,263	19,178
Long-Term Debt	2,201	1,576	1,105	1,904	1,000	-
Long-Term Leases	1,884	1,285	1,213	1,583	1,996	1,350
Pension & Post-Retirement Benefits	2,033	1,301	545.82	-	1,328	1,491
Other Long-Term Liabilities	1,895	1,941	3,422	3,417	3,542	3,615
Total Liabilities	45,085	42,759	35,464	34,231	32,129	25,634
Common Stock	15,490	15,490	15,490	15,490	15,490	15,490
Additional Paid-In Capital	63,621	63,621	63,621	63,621	63,621	63,502
Retained Earnings	-51,559	-47,817	-38,175	-26,354	-29,255	-20,640
Comprehensive Income & Other	76.86	81.67	57.07	86.29	64.05	-50.28
Total Common Equity	27,629	31,376	40,993	52,844	49,920	58,302
Minority Interest	-3,268	-2,815	-2,235	-1,436	-1,537	-1,559
Shareholders' Equity	24,361	28,561	38,758	51,408	48,383	56,743
Total Liabilities & Equity	69,446	71,320	74,221	85,639	80,512	82,377
Total Debt	27,798	24,689	17,501	18,678	16,474	10,245
Net Cash (Debt)	-26,484	-19,242	-13,141	-10,229	-6,289	-1,199
Net Cash Per Share	-854.52	-621.10	-424.17	-330.17	-203.02	-38.71
Filing Date Shares Outstanding	30.44	30.98	30.98	30.98	30.98	30.98
Total Common Shares Outstanding	30.44	30.98	30.98	30.98	30.98	30.98
Working Capital	-1,448	3,084	12,979	20,872	22,242	28,172
Book Value Per Share	907.68	1012.78	1323.22	1705.75	1611.38	1881.94
Tangible Book Value	26,914	30,607	40,190	52,037	49,078	57,672
Tangible Book Value Per Share	884.18	987.96	1297.29	1679.70	1584.20	1861.59
Land	8,811	8,811	8,864	9,408	9,329	7,060
Buildings	3,328	14,756	14,739	18,178	18,129	17,637
Machinery	4,795	30,693	30,233	26,893	26,807	27,563
Construction In Progress	473.04	-	7.24	4,157	1,430	191.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.